687 results on '"Willems, Stefan M."'
Search Results
52. supplemental figure legend from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
53. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma
54. Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI
55. Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck
56. Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
57. Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies
58. One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides
59. Assessment of algorithms for mitosis detection in breast cancer histopathology images
60. Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivity
61. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
62. Resection of early oral squamous cell carcinoma with positive or close margins: Relevance of adjuvant treatment in relation to local recurrence: Margins of 3 mm as safe as 5 mm
63. The estimation of tumor cell percentage for molecular testing by pathologists is not accurate
64. Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis: Inadequate biomarker for one‐step nucleic acid amplification implementation in sentinel lymph node biopsy procedure
65. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma
66. FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
67. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors
68. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review
69. Response to “Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence”
70. Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort
71. Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis: Impact of COVID-19 on head and neck cancer
72. Additional file 1 of Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands
73. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
74. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer
75. Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults
76. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis
77. Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
78. Excessive toxicity of cabozantinib in a phase II study in patients with recurrent and/or metastatic salivary gland cancer
79. False-negative PD-L1 immunostaining in ethanol-fixed EBUS-TBNA specimens of non-small cell lung cancer patients
80. The Hidden Link of Exosomes to Head and Neck Cancer
81. SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target
82. The potential of MET immunoreactivity for prediction of lymph node metastasis in early tongue squamous cell carcinoma
83. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas
84. Peptide and protein imaging mass spectrometry in cancer research
85. High-grade transformation/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance
86. Emerging entities and new diagnostic markers for head and neck soft tissue and bone tumors
87. A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma
88. A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses
89. P-28 The potential of MET immunoreactivity for prediction of lymph node metastasis in early tongue squamous cell carcinoma
90. P-252 The impact of the COVID-19 pandemic on the incidence, stage, and initial treatment of patients with head and neck cancer in the Netherlands
91. False‐negative programmed death‐ligand 1 immunostaining in ethanol‐fixed endobronchial ultrasound‐guided transbronchial needle aspiration specimens of non‐small‐cell lung cancer patients
92. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2
93. Detailed imaging and genetic analysis reveal a secondary BRAFL505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib
94. Comparison of Next-Generation Sequencing and Mutation-Specific Platforms in Clinical Practice
95. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
96. Use of the 2-μm continuous wave thulium laser for the resection of oral squamous cell carcinomas does not impair pathological assessment
97. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing
98. The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell Carcinoma
99. Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
100. Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.